Want to join the conversation?
$OMC said that, at current exchange rates, negative impact of FX on reported revenue will reduce revenue by about 1.5% during 2Q16 and approx. 1% for full year 2016. In addition, the company said that revenue from the recent acquisitions will be net positive for the year.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.